FOGHORN THERAPEUTICS INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$198M
↓-30.2% -$86Mvs FY2024
Total Liabilities
$307M
↓-7.0% -$23Mvs FY2024
Cash
$81M
↑+45.8% +$25Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $198M | $284M |
| Current Assets | $163M | $250M |
| Cash | $81M | $55M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $82M | $194M |
| Non-Current Assets | $35M | $34M |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $35M | $34M |
| Total Liab+Eq | $198M | $284M |
| Current Liab. | $60M | $67M |
| Accounts Payable | $4M | $4M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $43M | $46M |
| Other CL | $12M | $18M |
| Non-Current Liab. | $247M | $263M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $247M | $263M |
| Equity | $-109M | $-46M |
| Retained Earnings | $632M | $558M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · FHTX · Comparing FY2025 vs FY2024